Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Daniel Cormack currently holds 14,810 shares of ONCOGENEX PHARMACEUTICALS, INC. (OGXI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Daniel Cormack has been a net seller of OGXI stock. They have purchased $19.9K and sold $611.3K worth of shares.
Scott Daniel Cormack's most recent insider trade was on Sep 8, 2017, when they sold 1,491 shares at $3.09 per share.
Scott Daniel Cormack serves as Executive at ONCOGENEX PHARMACEUTICALS, INC. (OGXI). They have executed 71 insider transactions totaling $631.2K over their tenure at the company.
Scott Daniel Cormack holds the position of Executive at ONCOGENEX PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Scott Daniel Cormack has shown a selling trading pattern, with $19.9K in total purchases and $611.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Scott Daniel Cormack was on Jul 30, 2012, when they sold $140.4K worth of OGXI shares. This transaction involved 34,167 shares at $4.11 per share.
Scott Daniel Cormack currently owns 14,810 shares of ONCOGENEX PHARMACEUTICALS, INC. (OGXI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Daniel Cormack's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Daniel Cormack has 71 Form 4 filings on record as an insider at ONCOGENEX PHARMACEUTICALS, INC..
Set alerts for Scott Daniel Cormack and 40,000+ other insiders.